Eileen Johnson
Amgen (United States)(US)
Publications by Year
Research Areas
Coagulation, Bradykinin, Polyphosphates, and Angioedema, Neuropeptides and Animal Physiology, Chemical Synthesis and Analysis, Peptidase Inhibition and Analysis, Pain Mechanisms and Treatments
Most-Cited Works
- → Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists(2008)38 cited
- → Identification of Potent, Selective, and Metabolically Stable Peptide Antagonists to the Calcitonin Gene-Related Peptide (CGRP) Receptor(2008)34 cited
- → Targeting the bradykinin B1 receptor to reduce pain(2006)31 cited
- → Identification of a Nonpeptidic and Conformationally Restricted Bradykinin B1 Receptor Antagonist with Anti-Inflammatory Activity(2007)26 cited
- → Potent Nonpeptide Antagonists of the Bradykinin B1 Receptor: Structure−Activity Relationship Studies with Novel Diaminochroman Carboxamides(2007)26 cited
- → Aryl sulfones as novel Bradykinin B1 receptor antagonists for treatment of chronic pain(2008)20 cited
- → Inflammatory pain in the rabbit: A new, efficient method for measuring mechanical hyperalgesia in the hind paw(2007)19 cited
- → A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core(2006)18 cited
- → Peptide antagonists of the calcitonin gene‐related peptide (CGRP) receptor with improved pharmacokinetics and pharmacodynamics(2013)13 cited
- → 3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation(2011)8 cited